Cargando…

The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome

OBJECTIVES: Contradictory results have been reported regarding the association between polycystic ovary syndrome (PCOS) and cardiovascular disease (CVD). We assessed the cardiometabolic phenotype and prevalence of CVD in middle‐aged women with PCOS, compared with age‐matched controls from the genera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meun, Cindy, Gunning, Marlise N, Louwers, Yvonne V, Peters, Henrike, Roos‐Hesselink, Jolien, Roeters van Lennep, Jeanine, Rueda Ochoa, Oscar‐Leonel, Appelman, Yolande, Lambalk, Nils, Boersma, Eric, Kavousi, Maryam, Fauser, Bart CJM, Laven, Joop SE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003818/ https://www.ncbi.nlm.nih.gov/pubmed/31638273 http://dx.doi.org/10.1111/cen.14117

Ejemplares similares

The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study
por: Gunning, Marlise N., et al.
Publicado: (2020)

Efficacy and Safety of High Potent P2Y(12) Inhibitors Prasugrel and Ticagrelor in Patients With Coronary Heart Disease Treated With Dual Antiplatelet Therapy: A Sex‐Specific Systematic Review and Meta‐Analysis
por: Schreuder, Michelle M., et al.
Publicado: (2020)

Aging, Cardiovascular Risk, and SHBG Levels in Men and Women From the General Population
por: Aribas, Elif, et al.
Publicado: (2021)

Cardiovascular RiskprofilE - IMaging and gender-specific disOrders (CREw-IMAGO): rationale and design of a multicenter cohort study
por: Zoet, Gerbrand A., et al.
Publicado: (2017)

Characteristics of polycystic ovary syndrome throughout life
por: Louwers, Yvonne V., et al.
Publicado: (2020)

Integration of sex and gender in cardiovascular medicine: a scientific and clinical imperative
por: Kavousi, Maryam, et al.
Publicado: (2023)

Sex steroids and sex steroid‐binding globulin levels amongst middle‐aged and elderly men and women from general population
por: Aribas, Elif, et al.
Publicado: (2022)

MON-208 Association Study of AMH Promoter Polymorphisms and Serum AMH Levels in PCOS Patients
por: Moolhuijsen, Loes, et al.
Publicado: (2019)

Prevalence of microvascular angina among patients with stable symptoms in the absence of obstructive coronary artery disease: a systematic review
por: Aribas, Elif, et al.
Publicado: (2021)

Hypertensive disorders of pregnancy and subsequent maternal cardiovascular health
por: Bergen, Nienke E., et al.
Publicado: (2018)

Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
por: van der Ham, Kim, et al.
Publicado: (2023)

Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome
por: Moolhuijsen, Loes M E, et al.
Publicado: (2022)

Bone morphogenetic proteins and the polycystic ovary syndrome
por: van Houten, E Leonie AF, et al.
Publicado: (2013)

Are Dieting and Dietary Inadequacy a Second Hit in the Association with Polycystic Ovary Syndrome Severity?
por: Huijgen, Nicole A., et al.
Publicado: (2015)

Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome
por: Caanen, Mirte R, et al.
Publicado: (2020)

Follicle Stimulating Hormone Receptor (FSHR) Polymorphisms and Polycystic Ovary Syndrome (PCOS)
por: Laven, Joop S. E.
Publicado: (2019)

Questionnaire survey on cardiologists’ view and management of coronary microvascular disease in clinical practice
por: Aribas, E., et al.
Publicado: (2019)

The effect of age on blood pressure response by 4‐week treatment perindopril: A pooled sex‐specific analysis of the EUROPA, PROGRESS, and ADVANCE trials
por: Schreuder, Michelle M., et al.
Publicado: (2021)

Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy
por: Benschop, Laura, et al.
Publicado: (2019)

Association Between Sex-Specific Risk Factors and Risk of New-Onset Atrial Fibrillation Among Women
por: Lu, Zuolin, et al.
Publicado: (2022)

Adverse Events Associated With PCSK9 Inhibitors: A Real‐World Experience
por: Gürgöze, Muhammed T., et al.
Publicado: (2018)

BMI-Associated Alleles Do Not Constitute Risk Alleles for Polycystic Ovary Syndrome Independently of BMI: A Case-Control Study
por: Louwers, Yvonne V., et al.
Publicado: (2014)

Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS
por: Jiskoot, Geranne, et al.
Publicado: (2023)

Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases
por: Al Dubayee, Mohammed, et al.
Publicado: (2022)

Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome
por: Fraser, Graeme L, et al.
Publicado: (2021)

Pregnancy Outcomes in Women with PCOS: Follow-Up Study of a Randomized Controlled Three-Component Lifestyle Intervention
por: Dietz de Loos, Alexandra, et al.
Publicado: (2023)

Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome
por: Day, Felix R., et al.
Publicado: (2015)

Trabecular bone density in middle-aged women with reproductive disorders
por: van Zwol-Janssens, Charissa, et al.
Publicado: (2023)

Incidental findings on coronary computed tomography in women with selected reproductive disorders
por: van der Ham, Kim, et al.
Publicado: (2022)

Sex Differences in Familial Hypercholesterolemia
por: Klevmoen, Marianne, et al.
Publicado: (2023)

Lifestyle treatment in women with polycystic ovary syndrome: predictors of weight loss and dropout
por: Jiskoot, Geranne, et al.
Publicado: (2022)

PMON206 Pregnancy Rate and Outcomes Following a Randomized Controlled Three-component Lifestyle Intervention in Women with PCOS
por: van der Ham, Kim, et al.
Publicado: (2022)

Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study
por: Krul-Poel, Y. H. M., et al.
Publicado: (2018)

Sexual Function in Women With Polycystic Ovary Syndrome: Design of an Observational Prospective Multicenter Case Control Study
por: Pastoor, Hester, et al.
Publicado: (2020)

Catamenial chest pain and spontaneous coronary artery dissection: A case report
por: Al Fatly, Zainab, et al.
Publicado: (2020)

Early Pregnancy Cardiovascular Health and Subclinical Atherosclerosis
por: Benschop, Laura, et al.
Publicado: (2019)

Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management
por: Sleutjes, Jasmijn A. M., et al.
Publicado: (2021)

Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation
por: Sleutjes, Jasmijn A M, et al.
Publicado: (2022)

Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam Study
por: Brahimaj, Adela, et al.
Publicado: (2016)

Changes in eating behavior through lifestyle treatment in women with polycystic ovary syndrome (PCOS): a randomized controlled trial
por: Jiskoot, Geranne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8bsk963872r1fguceqt6f05e8d